Ortataxel

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ortataxel
Ortataxel.png
Systematic (IUPAC) name
(3aS,4R,7R,8aS,9S,10aR,12aS,13S,13aS)-7,12a-bis(acetyloxy)-4-({(2R,3S)-3-[tert-butoxycarbonyl)amino]-2-hydroxy-5-methylhexanoyl}oxy)-9-hydroxy-5,8a,14,14-tetramethyl-2,8-dioxo-3a,4,7,8,8a,9,10,10a,12,12a,12b,13-dodecahydro-6,13a-methano[1,3]dioxolo[8,9]cyclodeca[1,2-d][1]benzoxet-13-yl benzoate
Clinical data
Legal status ?
Identifiers
CAS number 186348-23-2 YesY
ATC code None
PubChem CID 10557575
UNII 8H61Y4E29N YesY
Chemical data
Formula C44H57NO17 
Mol. mass 871.92 g/mol
 YesY (what is this?)  (verify)

Ortataxel is a drug used in chemotherapy. As of June 2009, Spectrum Pharmaceuticals has the drug is in a Phase 2 clinical trial.